Trial · NCT07913555
Oliceridine for Remifentanil-Induced Postoperative Hyperalgesia
NCT07913555, Phase 4, Completed, Xingguo Xu
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Oliceridine for Remifentanil-Induced Postoperative Hyperalgesia. Trials, record NCT07913555. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07913555
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Oliceridine for Remifentanil-Induced Postoperative Hyperalgesia
- NCT number
- NCT07913555
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 130 participants, actual
- Lead sponsor
- Xingguo Xu
- Conditions
- Postoperative Hyperalgesia
- Interventions
- Oliceridine, sufentanil
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mechanical pain threshold around the incision at 6 hours post-surgery | 6 hours post-surgery | Mechanical pain thresholds around the surgical incision were measured using a von Frey tactile esthesiometer kit. |
| Secondary | Mechanical pain threshold around the incision | Preoperatively,at 30 minutes post-surgery, at 24 hours post-surgery, at 48 hours post-surgery | Measurements around the incision were taken at the midpoint of the incision and at 5 cm from each end of the incision, and the mean value of all measurement points was calculated. |
| Secondary | Mechanical pain threshold on the non-dominant forearm | Preoperatively, at 30 minutes post-surgery, at 6 hours post-surgery, at 24 hours post-surgery, at 48 hours post-surgery | Measurements on the non-dominant forearm were taken at 3, 6, and 9 cm from the antecubital crease, and the mean of the three values was calculated. |
| Secondary | Operative time | Intraoperatively | |
| Secondary | Extubation time | From the end of surgery until tracheal extubation, assessed for up to 2 hours postoperatively | Extubation time, defined as the time from the end of surgery to tracheal extubation |
| Secondary | PACU stay duration | From PACU admission until PACU discharge, assessed for up to 4 hours after PACU admission | PACU stay duration, defined as the time from PACU admission to PACU discharge |
| Secondary | Intraoperative propofol consumption | Intraoperatively | |
| Secondary | Intraoperative remifentanil consumption | Intraoperatively | |
| Secondary | Number of patients receiving atropine | Intraoperatively | |
| Secondary | Number of patients receiving vasopressors | Intraoperatively |
1 to 10 of 17Source ClinicalTrials.gov
See all 17 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07913555
GET https://conductscience.org/api/trials/v1/NCT07913555/registered